Ahmed Ludvigsen Al-Mashhadi

Oct 13, 2023 | nature.com | Ahmed Ludvigsen Al-Mashhadi |Christian Poulsen |Peter Brown

AbstractCurrently, the International Prognostic Index (IPI) is the most used and reported model for prognostication in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). IPI-like variations have been proposed, but only a few have been validated in different populations (e.g., revised IPI (R-IPI), National Comprehensive Cancer Network IPI (NCCN-IPI)).